Fluorescence standard, and the use thereof

Details for Australian Patent Application No. 2009237945 (hide)

Owner QIAGEN Lake Constance GmbH

Inventors Faulstich, Konrad; Haberstroh, Klaus

Agent Davies Collison Cave

Pub. Number AU-A-2009237945

PCT Pub. Number WO2009/127424

Priority 08007513.8 17.04.08 EP

Filing date 17 April 2009

Wipo publication date 22 October 2009

International Classifications

B01L 3/00 (2006.01) Containers or dishes for laboratory use, e.g. laboratory glassware

G01J 1/58 (2006.01) Photometry, e.g. photographic exposure meter

G01N 21/27 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light

G01N 21/64 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light - Fluorescence

G01T 1/36 (2006.01) Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation

G07D 7/12 (2006.01) Testing paper currency, securities, bonds, or similar valuable papers for genuineness

G01K 11/32 (2006.01) Measuring temperature based on physical or chemical changes not covered by group , , , or

G01N 23/223 (2006.01) Investigating or analysing materials by the use of wave or particle radiation not covered by group or , e.g. X-rays, neutrons

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/127424 Priority application(s): WO2009/127424

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009237963-Process for purifying an alpha-keto ester

2009237938-Quinoline derivatives as AXL kinase inhibitors